• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无血清质量和数量控制培养提高了从结缔组织病患者采集的外周血单个核细胞的血管生成潜力。

Serum-free Quality and Quantity Control Culture Improves the Angiogenic Potential of Peripheral Blood Mononuclear Cells Harvested from Patients with Connective Tissue Diseases.

作者信息

Furukawa Satomi, Hirano Rie, Sugawara Ai, Fujimura Satoshi, Tanaka Rica

机构信息

Division of Regenerative Therapy, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Center for Genomic and Regenerative Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

J Plast Reconstr Surg. 2024 May 10;3(4):157-164. doi: 10.53045/jprs.2022-0050. eCollection 2024 Oct 27.

DOI:10.53045/jprs.2022-0050
PMID:40104559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11912996/
Abstract

OBJECTIVES

The number and quality of endothelial progenitor cells decrease in patients with connective tissue diseases. This limits the efficacy of mononuclear cell therapy for ischemic ulcers associated with connective tissue diseases. To overcome these problems, we developed a serum-free quality and quantity control culture method that potentially improves the function of endothelial progenitor cells and expands their numbers. Here, we show the effect of quality and quantity control culture on mononuclear cells from patients with connective tissue diseases.

METHODS

Peripheral blood mononuclear cells were isolated from C57BL/6JJmsSlc- mice with systemic lupus erythematosus, patients with connective tissue diseases, and healthy volunteers. Mononuclear cells were cultured using the quality and quantity control culture method, and the number of endothelial progenitor cells was analyzed using flow cytometry, an endothelial progenitor cell culture assay, and an endothelial progenitor cell colony-forming assay. Flow cytometry was also used to examine mononuclear cell subpopulations. A human umbilical vein endothelial cell tube-forming assay was used to examine the function of quality and quantity control cultured mononuclear cells.

RESULTS

Mice with systemic lupus erythematosus showed a significantly lower number of endothelial progenitor cells, which increased to the same levels as those of the control mice after quality and quantity control culture. In humans, the numbers of endothelial progenitor cells and M2 macrophages were significantly increased and the number of proinflammatory cells was decreased after quality and quantity control culture in both healthy volunteers and patients with connective tissue diseases. The human umbilical vein endothelial cell tube formation assay showed higher angiogenic potential in quality and quantity control cultured mononuclear cells from patients with connective tissue diseases than that in quality and quantity control cultured mononuclear cells from healthy controls.

CONCLUSIONS

Our study suggests that the quality and quantity control culture method is effective in recovering the angiogenic ability of mononuclear cells from patients with connective tissue diseases.

摘要

目的

结缔组织病患者体内内皮祖细胞的数量和质量会下降。这限制了单核细胞疗法对结缔组织病相关缺血性溃疡的疗效。为克服这些问题,我们开发了一种无血清的质量和数量控制培养方法,该方法有可能改善内皮祖细胞的功能并增加其数量。在此,我们展示了质量和数量控制培养对结缔组织病患者单核细胞的影响。

方法

从患有系统性红斑狼疮的C57BL/6JJmsSlc-小鼠、结缔组织病患者和健康志愿者中分离外周血单核细胞。使用质量和数量控制培养方法培养单核细胞,并通过流式细胞术、内皮祖细胞培养测定法和内皮祖细胞集落形成测定法分析内皮祖细胞的数量。流式细胞术还用于检测单核细胞亚群。使用人脐静脉内皮细胞管形成测定法检测质量和数量控制培养的单核细胞的功能。

结果

患有系统性红斑狼疮的小鼠内皮祖细胞数量显著降低,经过质量和数量控制培养后增加到与对照小鼠相同的水平。在人类中,健康志愿者和结缔组织病患者经过质量和数量控制培养后,内皮祖细胞和M2巨噬细胞的数量均显著增加,促炎细胞数量减少。人脐静脉内皮细胞管形成测定显示,结缔组织病患者经质量和数量控制培养的单核细胞比健康对照经质量和数量控制培养的单核细胞具有更高的血管生成潜力。

结论

我们的研究表明,质量和数量控制培养方法可有效恢复结缔组织病患者单核细胞的血管生成能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/f41cb7099104/jprs-03-04-0157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/9636642f4c0f/jprs-03-04-0157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/df17a13fc9e9/jprs-03-04-0157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/a9e25901d5d2/jprs-03-04-0157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/f41cb7099104/jprs-03-04-0157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/9636642f4c0f/jprs-03-04-0157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/df17a13fc9e9/jprs-03-04-0157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/a9e25901d5d2/jprs-03-04-0157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4981/11912996/f41cb7099104/jprs-03-04-0157-g004.jpg

相似文献

1
Serum-free Quality and Quantity Control Culture Improves the Angiogenic Potential of Peripheral Blood Mononuclear Cells Harvested from Patients with Connective Tissue Diseases.无血清质量和数量控制培养提高了从结缔组织病患者采集的外周血单个核细胞的血管生成潜力。
J Plast Reconstr Surg. 2024 May 10;3(4):157-164. doi: 10.53045/jprs.2022-0050. eCollection 2024 Oct 27.
2
Quality and Quantity-Cultured Human Mononuclear Cells Improve Human Fat Graft Vascularization and Survival in an In Vivo Murine Experimental Model.质量和数量培养的人单核细胞改善体内实验鼠模型中人脂肪移植物的血管化和存活。
Plast Reconstr Surg. 2021 Feb 1;147(2):373-385. doi: 10.1097/PRS.0000000000007580.
3
Vasculogenic conditioning of peripheral blood mononuclear cells promotes endothelial progenitor cell expansion and phenotype transition of anti-inflammatory macrophage and T lymphocyte to cells with regenerative potential.外周血单个核细胞的血管生成预处理可促进内皮祖细胞的扩增以及抗炎性巨噬细胞和T淋巴细胞向具有再生潜能细胞的表型转变。
J Am Heart Assoc. 2014 Jun 25;3(3):e000743. doi: 10.1161/JAHA.113.000743.
4
Human peripheral blood mononuclear cells enriched in endothelial progenitor cells via quality and quantity controlled culture accelerate vascularization and wound healing in a porcine wound model.通过质量和数量控制培养富集人外周血单核细胞中的内皮祖细胞可加速猪创面模型中的血管生成和伤口愈合。
Cell Transplant. 2018 Jul;27(7):1068-1079. doi: 10.1177/0963689718780307. Epub 2018 Jul 5.
5
Synergistic effect of ex-vivo quality and quantity cultured mononuclear cells and mesenchymal stem cell therapy in ischemic hind limb model mice.体外培养的单核细胞质量和数量与间充质干细胞疗法对缺血后肢模型小鼠的协同作用。
Regen Ther. 2024 Aug 29;26:663-670. doi: 10.1016/j.reth.2024.08.013. eCollection 2024 Jun.
6
Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing.糖尿病患者外周血单个核细胞的体外培养促进血管生成性创面愈合。
Stem Cells Transl Med. 2021 Jun;10(6):895-909. doi: 10.1002/sctm.20-0309. Epub 2021 Feb 18.
7
Novel culture media enhances mononuclear cells from patients with chronic limb-threatening ischemia to increase vasculogenesis and anti-inflammatory effect.新型培养基增强慢性肢体严重缺血患者的单核细胞,以增加血管生成和抗炎作用。
Stem Cell Res Ther. 2021 Sep 28;12(1):520. doi: 10.1186/s13287-021-02592-3.
8
Novel cell therapy with cultured peripheral blood mononuclear cells significantly impacts angiogenesis in the murine ischemic limb model.采用培养的外周血单个核细胞进行的新型细胞疗法对小鼠缺血肢体模型中的血管生成有显著影响。
Regen Ther. 2024 Jun 20;26:299-307. doi: 10.1016/j.reth.2024.06.009. eCollection 2024 Jun.
9
Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis.无血清质量控制和数量培养集落形成内皮祖细胞血管生成的研究。
Stem Cells Transl Med. 2012 Feb;1(2):160-71. doi: 10.5966/sctm.2011-0023. Epub 2012 Feb 6.
10
Scaling up the ex vivo expansion of human circulating CD34(+)progenitor cells with upregulation of angiogenic and anti-inflammatory potential.通过上调血管生成和抗炎潜能来扩大人循环CD34(+)祖细胞的体外扩增。
Cytotherapy. 2015 Dec;17(12):1777-84. doi: 10.1016/j.jcyt.2015.09.003. Epub 2015 Oct 21.

本文引用的文献

1
Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.系统性红斑狼疮中的内皮功能与内皮祖细胞
Nat Rev Rheumatol. 2022 May;18(5):286-300. doi: 10.1038/s41584-022-00770-y. Epub 2022 Apr 7.
2
Phase I/IIa Feasibility Trial of Autologous Quality- and Quantity-Cultured Peripheral Blood Mononuclear Cell Therapy for Non-Healing Extremity Ulcers.自体质量和数量培养的外周血单个核细胞治疗非愈合肢体溃疡的 I/IIa 期可行性试验。
Stem Cells Transl Med. 2022 Mar 17;11(2):146-158. doi: 10.1093/stcltm/szab018.
3
Current State and Issues of Regenerative Medicine for Rheumatic Diseases.
风湿病再生医学的现状与问题
Front Med (Lausanne). 2022 Jan 28;9:813952. doi: 10.3389/fmed.2022.813952. eCollection 2022.
4
MMP9 secreted from mononuclear cell quality and quantity culture mediates STAT3 phosphorylation and fibroblast migration in wounds.单核细胞质量和数量培养分泌的基质金属蛋白酶9介导伤口中信号转导和转录激活因子3的磷酸化和成纤维细胞迁移。
Regen Ther. 2021 Nov 4;18:464-471. doi: 10.1016/j.reth.2021.10.003. eCollection 2021 Dec.
5
Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement.系统性硬化症患者共表达M1和M2单核细胞/巨噬细胞表面标志物的外周细胞:与皮肤受累程度的关系。
Hum Immunol. 2021 Sep;82(9):634-639. doi: 10.1016/j.humimm.2021.03.009. Epub 2021 May 19.
6
Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing.糖尿病患者外周血单个核细胞的体外培养促进血管生成性创面愈合。
Stem Cells Transl Med. 2021 Jun;10(6):895-909. doi: 10.1002/sctm.20-0309. Epub 2021 Feb 18.
7
Rheumatoid arthritis CD14 monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease.类风湿性关节炎CD14单核细胞表现出代谢和炎症功能障碍,这是一种在疾病临床表现之前出现的表型。
Clin Transl Immunology. 2021 Jan 19;10(1):e1237. doi: 10.1002/cti2.1237. eCollection 2021.
8
The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis.内皮祖细胞在系统性硬化症血管损伤修复中的作用
Front Immunol. 2018 Jun 18;9:1383. doi: 10.3389/fimmu.2018.01383. eCollection 2018.
9
Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.自体细胞疗法治疗无选择重症肢体缺血患者的疗效和安全性:一项荟萃分析。
Curr Stem Cell Res Ther. 2018;13(4):265-283. doi: 10.2174/1574888X13666180313141416.
10
Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.简明综述:细胞疗法治疗肢体严重缺血:临床前和临床研究的综合综述。
Stem Cells. 2018 Feb;36(2):161-171. doi: 10.1002/stem.2751. Epub 2018 Jan 3.